The Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS App for use with the FreeStyle Libre 2 14-day glucose sensors in individuals 4 years of age and older with diabetes.
The FreeStyle Libre 2 iOS App allows users to get glucose readings directly onto their iPhones without having to perform routine fingersticks. By scanning the glucose sensor with the App, users will be able to receive their current glucose level, trend arrow, and glucose history. The App also includes an optional real-time glucose alarm to alert users when their glucose level is high or low. Moreover, users may share their glucose readings with health care professionals and caregivers using the FreeStyle LibreLinkUp App.
The FreeStyle Libre 2 iOS App is compatible with iPhones and will be available to download for free on the iOS App Store soon.
Kurt Midyett, MD, pediatric endocrinologist and medical director at Midwest Pediatric Specialists, commented: “Continuous glucose monitoring is one of the most significant health tech innovations in the last decade, and I see the life-changing benefits first-hand from my patients every day. As a doctor, it’s invaluable to receive my patients’ glucose data remotely via systems like LibreView – enabling more meaningful conversations with my patients, and ultimately, improving treatment decisions and their long-term health.”
Abbott’s FreeStyle® Libre 2 iOS App cleared in U.S., providing a seamless digital experience to simplify diabetes management. News release. Abbott. Accessed August 2, 2021. https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-2-ios-app-cleared-in-us-providing-a-seamless-digital-experience-to-simplify-diabetes-management-301346035.html.
This article originally appeared on MPR